儿童原发性纤毛运动障碍、囊性纤维化发病机制及基因诊断进展
Research Progress on Pathogenesis and Gene Diagnosis of Primary Ciliary Dyskinesia and Cystic Fibrosis in Children
DOI: 10.12677/ACM.2022.124419, PDF,   
作者: 刘 璇, 舒 畅:重庆医科大学附属儿童医院呼吸科;儿童发育疾病研究教育部重点实验室;国家儿童健康与疾病临床医学研究中心;儿童发育重大疾病国家国际科技合作基地;儿科学重庆市重点实验室,重庆
关键词: 原发性纤毛运动障碍囊性纤维化基因气道黏液纤毛清除系统Primary Ciliary Dyskinesia Cystic Fibrosis Genes Pulmonary Mucociliary Clearance
摘要: 在气道中,纤毛与气道黏液协同作用组成黏液纤毛清除系统清除呼吸道吸入的颗粒和病原体。正常情况下,纤毛通过有节律的摆动,将包裹异物或病原体的黏液排到咽喉部。低渗性黏液的主要作用包括屏障病原体入侵,保证纤毛正常摆动,并且气道黏液的固有免疫能够直接对病原体进行非特异性清除。本文将总结气道黏液纤毛清除的分子和细胞机制,并对其功能障碍导致的先天性疾病如原发性纤毛运动障碍、囊性纤维化的发病机制、基因诊断的最新进展进行综述。
Abstract: In the airway, the cilia work together with airway mucus to form a mucociliary clearance that removes particles and pathogens inhaled by the respiratory tract. Normally, the cilia move in rhythmic movements to expel mucus surrounding a foreign body or pathogen to the throat. The main effects of hypotonic mucus include barrier pathogen invasion, ensuring normal cilia movement, and innate immunity of airway mucus to directly and non-specifically eliminate pathogens. In this review, we will summarize the molecular and cellular mechanisms of ciliary clearance of airway mucus, and review the latest advances in genetic diagnosis of congenital diseases such as primary ciliary movement disorder, and cystic fibrosis caused by its dysfunction.
文章引用:刘璇, 舒畅. 儿童原发性纤毛运动障碍、囊性纤维化发病机制及基因诊断进展[J]. 临床医学进展, 2022, 12(4): 2912-2917. https://doi.org/10.12677/ACM.2022.124419

参考文献

[1] Bustamante-Marin, X.M. and Ostrowski, L.E. (2017) Cilia and Mucociliary Clearance. Cold Spring Harbor Perspectives in Biology, 9, a028241. [Google Scholar] [CrossRef] [PubMed]
[2] Kuek, L. and Lee, R. (2020) First Contact: The Role of Respiratory Cilia in Host-Pathogen Interactions in the Airways. American Journal of Physiology Lung Cellular and Molecular Physiology, 319, L603-L619. [Google Scholar] [CrossRef] [PubMed]
[3] 卢燕鸣, 周文静. 儿童气道黏液高分泌及清除机制[J]. 中国实用儿科杂志, 2018, 33(3): 175-179.
[4] 徐保平, 蔡栩栩, 朱春梅, 等. 儿童原发性纤毛运动障碍诊断与治疗专家共识[J]. 中华实用儿科临床杂志, 2018, 33(2): 94-99.
[5] Tilley, A., Walters, M., Shaykhiev, R., et al. (2015) Cilia Dysfunction in Lung Disease. Annual Review of Physiology, 77, 379-406. [Google Scholar] [CrossRef] [PubMed]
[6] Guan, Y., Yang, H., Yao, X., et al. (2021) Clinical and Genetic Spectrum of Children with Primary Ciliary Dyskinesia in China. Chest, 159, 1768-1781. [Google Scholar] [CrossRef] [PubMed]
[7] Guo, Z., Chen, W., Wang, L., et al. (2020) Clinical and Genetic Spectrum of Children with Primary Ciliary Dyskinesia in China. The Journal of Pediatrics, 225, 157-165.e5. [Google Scholar] [CrossRef] [PubMed]
[8] 王昊, 徐保平. 儿童原发性纤毛运动障碍遗传发病机制与基因诊断研究进展[J]. 中华实用儿科临床杂志, 2021, 36(10): 786-789.
[9] Knowles, M., Daniels, L., Davis, S., et al. (2013) Primary Ciliary Dyskinesia. Recent Advances in Diagnostics, Genetics, and Characterization of Clinical Disease. American Journal of Respiratory and Critical Care Medicine, 188, 913-922. [Google Scholar] [CrossRef
[10] Antony, D., Brunner, H.G. and Schmidts, M. (2021) Ciliary Dyneins and Dynein Related Ciliopathies. Cells, 10, 1885. [Google Scholar] [CrossRef] [PubMed]
[11] Pazour, G.J., Quarmby, L.M., Smith, A.O., et al. (2019) Cilia in Cystic Kidney and Other Diseases. Cellular Signalling, 69, Article ID: 109519. [Google Scholar] [CrossRef] [PubMed]
[12] Bustamante-Marin, X.M., Horani, A., Stoyanova, M., et al. (2020) Mutation of CFAP57, a Protein Required for the Asymmetric Targeting of a Subset of Inner Dynein Arms in Chlamydomonas, Causes Primary Ciliary Dyskinesia. PLoS Genetics, 16, e1008691. [Google Scholar] [CrossRef] [PubMed]
[13] Lee, C., Cox, R., Papoulas, O., et al. (2020) Functional Partitioning of a Liquid-Like Organelle during Assembly of Axonemal Dyneins. eLife, 9, e58662. [Google Scholar] [CrossRef
[14] Brennan, S., Ferkol, T. and Davis, S. (2021) Emerging Genotype-Phenotype Relationships in Primary Ciliary Dyskinesia. International Journal of Molecular Sciences, 22, 8272. [Google Scholar] [CrossRef] [PubMed]
[15] Wheway, G., et al. (2019) Opportunities and Challenges for Molecular Understanding of Ciliopathies—The 100,000 Genomes Project. Frontiers in Genetics, 10, Article No. 127. [Google Scholar] [CrossRef] [PubMed]
[16] Zhao, X., Bian, C., Liu, K., et al. (2021) Clinical Characteristics and Genetic Spectrum of 26 Individuals of Chinese Origin with Primary Ciliary Dyskinesia. Orphanet Journal of Rare Diseases, 16, 293. [Google Scholar] [CrossRef] [PubMed]
[17] Horani, A. and Ferkol, T. (2018) Advances in the Genetics of Primary Ciliary Dyskinesia: Clinical Implications. Chest, 154, 645-652. [Google Scholar] [CrossRef] [PubMed]
[18] Zariwala, M., Knowles, M. and Omran, H. (2007) Genetic Defects in Ciliary Structure and Function. Annual Review of Physiology, 69, 423-450. [Google Scholar] [CrossRef] [PubMed]
[19] Farrell, P., White, T., Ren, C., et al. (2017) Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation. The Journal of Pediatrics, 181S, S4-S15.e1. [Google Scholar] [CrossRef] [PubMed]
[20] 郭伟. 囊性纤维化的诊断与治疗进展[J]. 中华实用儿科临床杂志, 2018, 33(14): 1118-1120.
[21] Ehre, C., Ridley, C. and Thornton, D.J. (2014) Cystic Fibrosis: An Inherited Disease Affecting Mucin-Producing Organs. The International Journal of Biochemistry & Cell Biology, 52, 136-145. [Google Scholar] [CrossRef] [PubMed]
[22] Choi, S.H. and Engelhardt, J.F. (2021) Gene Therapy for Cystic Fibrosis: Lessons Learned and Paths Forward. Molecular Therapy: The Journal of the American Society of Gene Therapy, 29, 428-430. [Google Scholar] [CrossRef] [PubMed]
[23] Mckelvey, M.C., Brown, R., Ryan, S.A.M., et al. (2021) Proteases, Mucus, and Mucosal Immunity in Chronic Lung Disease. International Journal of Molecular Sciences, 22, 5018. [Google Scholar] [CrossRef] [PubMed]
[24] 王琳, 聂宏光. 离子转运参与肺纤维化发病机制的研究进展[J]. 生理科学进展, 2020, 51(1): 33-35.
[25] Raraigh, K.S., Aksit, M.A., Hetrick, K., Pace, R.G., Ling, H., O’Neal, W., Blue, E., Zhou, Y.H., Bamshad, M.J., Blackman, S.M., Gibson, R.L., Knowles, M.R. and Cutting, G.R. (2021) Complete CFTR Gene Sequencing in 5,058 Individuals with Cystic Fibrosis Informs Variant-Specific Treatment. Journal of Cystic Fibrosis. (Epub Ahead of Print) [Google Scholar] [CrossRef] [PubMed]
[26] Lee, J., Cho, A., Huang, E., et al. (2021) Gene Therapy for Cystic Fibrosis: New Tools for Precision Medicine. Journal of Translational Medicine, 19, 452. [Google Scholar] [CrossRef] [PubMed]
[27] 高立伟, 徐保平. 关注儿童囊性纤维化[J]. 中华实用儿科临床杂志, 2018, 33(4): 309-312.
[28] Ren, C., Morgan, R., Oermann, C., et al. (2018) Cystic Fibrosis Foundation Pulmonary Guidelines. Use of Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy in Patients with Cystic Fibrosis. Annals of the American Thoracic Society, 15, 271-280. [Google Scholar] [CrossRef
[29] Ring, A.M., Buchvald, F., Holgersen, M.G., et al. (2018) Fitness and Lung Function in Children with Primary Ciliary Dyskinesia and Cystic Fibrosis. Respiratory Medicine, 139, 79-85. [Google Scholar] [CrossRef] [PubMed]